Mirae Asset Global Etfs Holdings Ltd. Immunity Bio, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 83,109 shares of IBRX stock, worth $452,944. This represents 0.0% of its overall portfolio holdings.
Number of Shares
83,109Holding current value
$452,944% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IBRX
# of Institutions
214Shares Held
63.3MCall Options Held
1.44MPut Options Held
3.84M-
Vanguard Group Inc Valley Forge, PA13.8MShares$75.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$62.3 Million0.0% of portfolio
-
State Street Corp Boston, MA7.86MShares$42.9 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.85MShares$21 Million0.0% of portfolio
-
Jane Street Group, LLC New York, NY1.72MShares$9.35 Million0.01% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $2.18B
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...